MACK Annual Non Current Assets
$4000.00
-$4000.00-50.00%
31 December 2023
Summary:
As of January 22, 2025, MACK annual long term assets is $4000.00, with the most recent change of -$4000.00 (-50.00%) on December 31, 2023. During the last 3 years, it has fallen by -$228.00 thousand (-98.28%).MACK Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Quarterly Non Current Assets
$3000.00
-$1000.00-25.00%
01 March 2024
Summary:
As of January 22, 2025, MACK quarterly long term assets is $3000.00, with the most recent change of -$1000.00 (-25.00%) on March 1, 2024. Over the past year, it has dropped by -$2000.00 (-40.00%).MACK Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.0% | -40.0% |
| 3 y3 years | -98.3% | -40.0% |
| 5 y5 years | -100.0% | -40.0% |
MACK Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -100.0% | -100.0% |
Merrimack Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $3000.00(-25.0%) |
| Dec 2023 | $19.18 M(-3.2%) | $4000.00(-20.0%) |
| Sept 2023 | - | $5000.00(-16.7%) |
| June 2023 | - | $6000.00(-14.3%) |
| Mar 2023 | - | $7000.00(-12.5%) |
| Dec 2022 | $19.83 M(+35.0%) | $8000.00(-11.1%) |
| Sept 2022 | - | $9000.00(-10.0%) |
| June 2022 | - | $10.00 K(-60.0%) |
| Mar 2022 | - | $25.00 K(-62.1%) |
| Dec 2021 | $14.68 M(-11.2%) | $66.00 K(-38.9%) |
| Sept 2021 | - | $108.00 K(-27.5%) |
| June 2021 | - | $149.00 K(-22.0%) |
| Mar 2021 | - | $191.00 K(-17.7%) |
| Dec 2020 | $16.54 M(-11.5%) | $232.00 K(-15.3%) |
| Sept 2020 | - | $274.00 K(-13.0%) |
| June 2020 | - | $315.00 K(-77.0%) |
| Mar 2020 | - | $1.37 M(-1.5%) |
| Dec 2019 | $18.69 M(-75.4%) | $1.39 M(-43.1%) |
| Sept 2019 | - | $2.44 M(-1.6%) |
| June 2019 | - | $2.48 M(-76.7%) |
| Mar 2019 | - | $10.66 M(-14.3%) |
| Dec 2018 | $76.10 M(-19.9%) | $12.44 M(-25.3%) |
| Sept 2018 | - | $16.65 M(-10.0%) |
| June 2018 | - | $18.50 M(-9.3%) |
| Mar 2018 | - | $20.39 M(-8.5%) |
| Dec 2017 | $95.05 M | $22.28 M(-72.9%) |
| Sept 2017 | - | $82.27 M(+14.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $71.89 M(+221.4%) |
| Mar 2017 | - | $22.37 M(-7.0%) |
| Dec 2016 | $57.44 M(-71.5%) | $24.05 M(-16.5%) |
| Sept 2016 | - | $28.79 M(-7.1%) |
| June 2016 | - | $30.99 M(-3.9%) |
| Mar 2016 | - | $32.25 M(-3.7%) |
| Dec 2015 | $201.39 M(+52.5%) | $33.49 M(+5.4%) |
| Sept 2015 | - | $31.76 M(+5.3%) |
| June 2015 | - | $30.16 M(+8.8%) |
| Mar 2015 | - | $27.72 M(+4.8%) |
| Dec 2014 | $132.06 M(-20.8%) | $26.44 M(-0.1%) |
| Sept 2014 | - | $26.46 M(+1.9%) |
| June 2014 | - | $25.96 M(-0.5%) |
| Mar 2014 | - | $26.10 M(+1.3%) |
| Dec 2013 | $166.64 M(+29.9%) | $25.77 M(+7.6%) |
| Sept 2013 | - | $23.96 M(+12.1%) |
| June 2013 | - | $21.37 M(+3.9%) |
| Mar 2013 | - | $20.57 M(-0.5%) |
| Dec 2012 | $128.30 M(+95.6%) | $20.67 M(+8.1%) |
| Sept 2012 | - | $19.13 M(+4.1%) |
| June 2012 | - | $18.38 M(-1.5%) |
| Mar 2012 | - | $18.66 M(-5.3%) |
| Dec 2011 | $65.59 M(+80.7%) | $19.71 M(-0.1%) |
| Sept 2011 | - | $19.72 M(-3.6%) |
| June 2011 | - | $20.45 M(-0.4%) |
| Mar 2011 | - | $20.53 M(-3.5%) |
| Dec 2010 | $36.29 M(-41.0%) | $21.29 M |
| Dec 2009 | $61.51 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual non current assets year-on-year change?
- What is Merrimack Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly non current assets year-on-year change?
What is Merrimack Pharmaceuticals annual long term assets?
The current annual non current assets of MACK is $4000.00
What is the all time high annual non current assets for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual long term assets is $33.49 M
What is Merrimack Pharmaceuticals annual non current assets year-on-year change?
Over the past year, MACK annual long term assets has changed by -$4000.00 (-50.00%)
What is Merrimack Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of MACK is $3000.00
What is the all time high quarterly non current assets for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly long term assets is $82.27 M
What is Merrimack Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, MACK quarterly long term assets has changed by -$2000.00 (-40.00%)